Trial intelligence / Profile preview

Ixabepilone Rollover Study in Metastatic Breast Cancer

NCT01027208Phase 2Completed

Sponsor
R-Pharm
Start
Dec 2006
Primary completion
Jan 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ixabepilone in breast cancer, sponsored by R-Pharm. Started Dec 2006; status: completed.

02

Drugs

ixabepilone
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT01027208.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01027208.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call